Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Anesthesiology|April 14, 1999
Factors affecting the pharmacokinetic characteristics of rapacuroniumD M Fisher, R Kahwaji, D Bevan, et al.
Anesthesia and Analgesia|September 4, 1999
The influence of renal function on the pharmacokinetics and pharmacodynamics and simulated time course of doxacuriumD M Fisher, K S Reynolds, V D Schmith, et al.
British Journal of Anaesthesia|November 1, 1985
Effect of renal failure on laudanosine excretion in manM R Fahey, S M Rupp, C Canfell, et al.
Anesthesiology|October 1, 1989
Washin and washout of isoflurane administered via bubble oxygenators during hypothermic cardiopulmonary bypassN A Nussmeier, M L Lambert, G J Moskowitz, et al.
Anesthesiology|December 1, 1984
The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failureM R Fahey, S M Rupp, D M Fisher, et al.
Anesthesiology|November 1, 1992
Pharmacokinetics of rocuronium bromide (ORG 9426) in patients with normal renal function or patients undergoing cadaver renal transplantationJ Szenohradszky, D M Fisher, V Segredo, et al.
British Journal of Anaesthesia|December 1, 1988
Pipecuronium and pancuronium: comparison of pharmacokinetics and duration of actionJ E Caldwell, K P Castagnoli, P C Canfell, et al.
Anesthesiology|April 1, 1995
Edrophonium increases mivacurium concentrations during constant mivacurium infusion, and large doses minimally antagonize paralysisP S Hart, P M Wright, R Brown, et al.
Anesthesiology|July 1, 1986
Elimination of atracurium in humans: contribution of Hofmann elimination and ester hydrolysis versus organ-based eliminationD M Fisher, P C Canfell, M R Fahey, et al.
Anesthesiology|January 1, 1989
The influence of renal failure on the pharmacokinetics and duration of action of pipecuronium bromide in patients anesthetized with halothane and nitrous oxideJ E Caldwell, P C Canfell, K P Castagnoli, et al.
Pageof 10